179 related news articles for

One of the most exciting developments in ovarian cancer treatment in decades will form the basis of a new two-year research project at Hudson Institute, thanks to the generosity of the CanToo Foundation.…  Read more

Two unique Hudson Institute research projects have been chosen among eight nationally to share in the largest-ever funding distribution from the Ovarian Cancer Research Foundation (OCRF), offering hope to women everywhere.…  Read more

In a significant advancement for pediatric cancer research, Dr Pouya Faridi—the head of the Translational Antigen Discovery Laboratory and Childhood Cancer Immunotherapy Program Lead—announced that his lab has been awarded three grants from Tour de Cure Australia.…  Read more

The latest discovery packs a double punch – identifying a genetic target for childhood brain cancer, plus a way to determine which patients are mostly likely to benefit from it.…  Read more

A diagnosis of ovarian cancer carries a dual threat – the disease itself and the danger of the cancer spreading – but the latest research from Hudson Institute has uncovered a crucial factor, leader cells, that are crucial to both.…  Read more

Research projects that will improve the lives of people with autoinflammatory diseases, hypertension, cancer and perinatal brain injury have been recognised in the latest National Health and Medical Research Council (NHMRC) Investigator Grants, announced by Federal Minister for Health and Ageing, The Hon Mark Butler MP.…  Read more

Hudson Institute’s Centre for Cancer Research is a major winner in the Medical Research Future Fund (MRFF) 2024 Paediatric Brain Cancer Research grants.…  Read more

Associate Professor Dan Gough and his team are studying how to make these cold tumours visible to the immune system and prevent them spreading to other parts of the body.…  Read more

Cancer kills three children every week in Australia – more than any other disease. And more than 1,000 children and adolescents are diagnosed with cancer each year – highlighting why our researchers are focused on trying to find much-needed cures and better treatments for children with cancer.…  Read more

Two remarkable Melbourne teenagers, Tianna and Raya fought and beat the odds against leukaemia, and are now aiming to help others who find themselves facing the same medical nightmare.…  Read more

Dr Catherine Carmichael aims to identify the key mechanisms that drive development of an aggressive form of childhood blood cancer, acute myeloid leukaemia (AML).…  Read more

Through this type of philanthropy, Lions have not just improved the chances of children with cancer living longer and better lives. Lions have also improved the likelihood that the next major breakthrough in paediatric cancer will come from Hudson Institute in Australia.…  Read more

There are few parts of the Australian community that remain untouched by ovarian cancer. The team at Spotlight Group Holdings, one of the nation’s largest retail organisations, is supporting Hudson Institute’s work to help find a cure and better early diagnostics for the deadly disease.…  Read more

At Hudson Institute, Minister for Medical Research Ben Carroll announced the establishment of the Victorian Paediatric Cancer Consortium Limited (VPCC Ltd), made possible by a $35 million investment from the Government and $10 million from the Children’s Cancer Foundation.…  Read more

Cancer remains the number-one disease-related killer of Australian children, so a new program at Hudson Institute of Medical Research has been established to specifically target one of the most deadly cancers – sarcoma.…  Read more

Through a greater understanding of H. pylori infection, we are identifying molecular targets that can be used for better diagnosis, new therapies and preventative treatments, such as vaccines, against the diseases caused by this bacterium.…  Read more

Their latest research, published in the esteemed journal, Nature, showed that the innate immune system produces a powerful weapon against ovarian cancer – interferon epsilon (IFNe) – a weapon just waiting to be harnessed to deliver an effective immunotherapy treatment option.…  Read more

For Associate Professor Simon Chu, the problem leading Hudson Institute’s research into rare ovarian cancers was getting access to large quantities of real-world data, and the solution came from a surprising place: social media.…  Read more

The Childhood Cancer Model Atlas leverages AI and global collaboration to accelerate treatments for paediatric solid and CNS tumours.…  Read more

Associate Professor Dan Gough and his team have developed sophisticated models of lung cancer which allow them to model disease progression and observe response to current treatments in patients.…  Read more

Cade Watts was only 15 when he died, but his family and friends are determined that his legacy will be large – their fundraiser for sarcoma research, Climbing for Cade, has made sure of that.…  Read more

Associate Professor Daniel Gough has received the first ever PASO Fellowship at Hudson Institute, securing the future of his ground-breaking lung cancer research.…  Read more

Thanks to an extraordinary funding commitment, Hudson Institute of Medical Research will be home to the My Room Children’s Cancer Charity Fellowship and Laboratory.…  Read more

A deadly form of children’s brain cancer that’s immune to chemotherapy is the target of new research at Hudson Institute, looking at the epigenome and immuno-therapies for answers.…  Read more

Hudson Institute researchers have had some great success in the recent NHMRC Grant rounds.…  Read more

Exciting research projects covering healthier pregnancy, safer birth and new forms of cancer treatment have attracted major funding in the form of NHMRC Investigator grants.…  Read more

H. pylori – short for Helicobacter pylori – colonises the stomach and is known to be linked to the development of stomach cancer. It is estimated that over half of the world’s population is infected with H. pylori, making it one of the most common bacterial infections.…  Read more

A strangely named pathway that’s crucial to bone growth has emerged as a key in the fight to treat the bone cancer osteosarcoma.…  Read more

Ten years of research has revealed a vital secret to how cancer cells work, and opened the door to potential new treatments.…  Read more

Jessica Clark calls herself the luckiest unlucky person in the world – but she still wants to know why she got ovarian cancer at such a young age.…  Read more

In medical research, the path from laboratory bench to patient bedside is usually a very long one. And when it comes to breakthroughs in specific testing for ovarian cancer, it is a path that no-one has yet navigated successfully.…  Read more

In a distinguished scientific career lasting four decades, Professor Paul Hertzog has just about seen it all – but seeing his team’s latest research published in the influential journal Nature was a proud moment.…  Read more

When it comes to rare forms of cancer, researchers and patients share the same problem – finding enough information from which to make informed decisions.…  Read more

Despite encountering more than her share of health challenges, 92-year-old Delva Walker has the most positive outlook you are ever likely to encounter.…  Read more

A new blood test is now being developed to improve ovarian cancer diagnosis, with the potential to reduce unnecessary surgery leading to better health outcomes, saving time, stress and money for patients and the healthcare system.…  Read more

The search for preventions and cures has turned inward – focussing on the immune system to stop ovarian cancer.…  Read more

A new class of anti-inflammatory drug is opening a world of possibilities for treating everything from neurological diseases to cancers.…  Read more

As in so many cases, a tragic bereavement – the death of her husband from stomach cancer – was the catalyst for Janine’s decision to donate to medical research.…  Read more

When it comes to treating disease, the medical profession is increasingly recognising that children are not just small adults: their bodies behave differently. …  Read more

Exciting new treatments for unmet medical needs including ovarian cancer have been awarded significant funding from Australia’s national biotechnology incubator, CUREator.…  Read more

The future of children with cancer is brighter today, with the announcement of significant funding from the Victorian government for paediatric cancer research.…  Read more

Researchers at Hudson Institute of Medical Research have shown a new drug that is incredibly effective in treating small cell lung cancer – doubling the usual survival time.…  Read more

It’s hard to imagine four words more frightening to a parent than “Your child has cancer”. Amid the fear and panic such a sentence creates, three-year-old Luca’s parents, Monique and Baden, had little choice but to trust in the best that medical science could offer.…  Read more

Some families are blessed to live lives free from the scourge of cancer … and then there are families like the Lordens. Four members of Ann Lorden’s family have endured their own battles with the dreaded disease – for a start, both Ann and her daughter are breast cancer survivors.…  Read more

There’s nothing in Luca Hall-Boggia’s winning smile or cheeky attitude to suggest the suffering he’s endured. You wouldn’t spot the small bald patch, amid his mess of dark, wavy hair, which is the only remaining evidence of the brain surgery that saved his life when he was just 3 years old.…  Read more

Six of the best early career researchers have been chosen to take part in the Hudson Institute 2023 Emerging Leaders Program. …  Read more

Ovarian cancer specialists have taken a novel path to advance their research – tapping into an international Facebook group to learn from members’ experiences.…  Read more

A single laboratory in south-east Melbourne is now the global hub for medical researchers looking to cure childhood cancer.…  Read more

The search for new therapies to treat a rare type of non-Hodgkins lymphoma has had an unexpected success – identifying a potential molecular target to treat other related forms of lymphoma as well.…  Read more

Two new candidates have been identified as crucial factors in maintaining good intestinal health.…  Read more

Hudson Institute researchers have featured prominently among the latest recipients of NHMRC Ideas Grants.…  Read more

Two Hudson Institute researchers at different stages of their careers have won sought-after Victorian Cancer Agency (VCA) Fellowships. Blood cancer specialist Dr Catherine Carmichael received the VCA Mid-Career Research Fellowship for her research into Acute Myeloid Leukaemia (AML), while Dr Claire Sun was awarded the VCA Early Career Research Fellowship to further her search for…  Read more

When the Lindner family generously requested donations to Hudson Institute’s paediatric brain cancer research in lieu of flowers after the passing of their daughter Jessica, their community rallied behind their wish. …  Read more

As a global leader in the field of childhood cancer research, Hudson Institute of Medical Research welcomes the Victorian Government’s pledge to invest $35 million in this area of vital need.…  Read more

The immune system wages a constant war against disease in all of us, and now researchers have identified a key immune molecule that could underpin a bowel cancer breakthrough.…  Read more

Dr Catherine Carmichael answers frequently asked questions about blood cancer. Dr Carmichael is a molecular cancer biologist and Head of the Leukaemia Modelling and Therapeutic Discovery Research group within the Centre for Cancer Research at Hudson Institute.…  Read more

A world-class Melbourne collaboration is set to beat the worst childhood cancers. …  Read more

If an army marches on its stomach, as the old saying goes, then the US Department of Defense (DoD) is investing wisely in Australian upper gastrointestinal cancer research.…  Read more

Researchers aim to beat cancer at its own game by identifying modulators of the innate immune system that drive it and applying the brakes before cancer takes hold.…  Read more

A new insight into RNA regulation has taken researchers a big step forward in understanding how the body creates platelets.…  Read more

Researchers in Melbourne have uncovered a stomach cancer trigger, providing vital clues to the origins of the world’s third-most-common cancer.…  Read more

Not even Covid-19 could stop a pioneer in the fight against rare ovarian cancers finishing his epic fundraising ride. In early May Dr Simon Chu took a break from the lab and put rubber on the road in the Ride4Research, aiming to cover 900km in 9 days from Canberra to Melbourne.…  Read more

For clinicians, detecting cancer is a victory in itself, but stopping its spread is crucial to a successful outcome. For Professor Ron Firestein, 2021 brought welcome results in that endeavour, thanks to the discovery that disabling two proteins together robs bowel cancer cells of their ability to express genes necessary for growth and spread.…  Read more

Pancreatic cancer is predicted to be the second leading cause of cancer-related death by 2030. While other cancer survival rates are improving, pancreatic cancer has been virtually unchanged for four decades.…  Read more

New light has been shone on the role of specific protein components of the immune system in both causing and preventing cancer.…  Read more

On 16 March we were delighted to welcome a group from Fire Rescue Victoria, who are generously supporting our research into the BRCA1 or BRCA2 mutations via the Firefighters Charity Fund. …  Read more

A pioneer in the fight against rare ovarian cancers is taking a break from the lab and putting rubber on the road as part of the Ride4Research.…  Read more

An RNA project with potential in both male infertility and cancer has been awarded significant funding by the Australian Research Council.…  Read more

Seeing their baby diagnosed with a rare ovarian cancer before her first birthday instantly made one Central Victorian family advocates for medical research.…  Read more

Hudson Institute of Medical Research is proud to be a recipient in the latest round of funding from the Ovarian Cancer Research Foundation (OCRF).…  Read more

Hudson Institute was proud to host the announcement of the Victorian Paediatric Cancer Consortium (VPCC).…  Read more

A colon cancer research breakthrough at Hudson Institute has shown that combining two types of drugs targeting gene expression stops cancer proliferation.…  Read more

A new understanding of the causes of small cell lung cancer (SCLC) could lead to more personalised treatments and lower mortality from this deadly disease.…  Read more

An ambitious project to identify and characterise the rarest and deadliest forms of brain cancer in children has received a welcome funding boost.…  Read more

A bacterium present in half the world’s population, Helicobacter pylori  is the target of new research aiming to develop a vaccine against stomach cancer.  …  Read more

Hudson Institute has again been recognised in the awarding of NHMRC Ideas Grants. These grants support innovative and creative research and build on Australia’s strong skills and international reputation in advanced health and medical research.…  Read more

Hudson Institute has again been recognised as a leader in medical research with our CEO & Director appointed to the Council of the National Health and Medical Research Council (NHMRC).…  Read more

At 18 months, Lachy developed fevers, vomiting and general tiredness. Doctors thought it was a daycare virus and he would get over it. Lachy had an 11 cm tumour in his abdomen and was diagnosed with Stage IV neuroblastoma, which had spread to his bone marrow.…  Read more

Researchers looking into one of the deadliest forms of cancer have made a big breakthrough by drilling down to the molecular level.…  Read more

Congratulations to Dr Vijesh Vaghjiani, Postdoctoral Scientist in the Developmental and Cancer Biology Research group who has been awarded one of two Sarcoma Research Grants by Australia and New Zealand Sarcoma Association (ANZSA).…  Read more

Hudson Institute researchers Dr Daniel Croagh and Professor Brendan Jenkins have  received a share of the Australian Pancreatic Cancer Foundation’s (PanKind) 2020 Collaborative Research Grant to help accelerate…  Read more

Six Early Career Researchers have been chosen for the 2021 Hudson Institute Emerging Leaders program.…  Read more

Hudson Institute researchers have developed a new gene therapy strategy to treat beta thalassaemia, an inherited disorder where the body doesn’t make enough haemoglobin in red blood cells. These disorders lead to altered production of both haemoglobin and red blood cells, causing serious life-threatening complications soon after birth. …  Read more

Drugs that are being trialled to treat leukaemia could also be used to fight bowel cancer after a breakthrough by Hudson Institute of Medical Research scientists.…  Read more

Hudson Institute researchers have shown for the first time that a diabetes drug called sitagliptin can limit tumour growth, and possibly extend survival rates from epithelial ovarian cancer, the most common and dangerous type of ovarian cancer.…  Read more

Congratulations to Professor Brendan Jenkins and his team, who have been awarded $288,536 from Cancer Council Victoria (CCV) to fund research into pancreatic cancer.…  Read more

Bone cancer treatments will be progressed thanks to the Victorian Cancer Agency Early Career Fellowship, which has been awarded to Dr Vijesh Vaghjiani, Postdoctoral Scientist, Developmental and Cancer Biology Research group.…  Read more

Hudson Institute has been successful in the NHMRC Ideas Grant round. Our researchers have been awarded four NHMRC Ideas Grants, totalling almost $4.1 million.…  Read more

Hudson Institute scientists have paved the way to potentially test new treatments for chronic obstructive pulmonary disease (COPD) and emphysema, following a discovery of the molecular drivers of these lung diseases.…  Read more

Congratulations to Dr Marius Dannappel and Dr Madara Ratnadiwakara who have been awarded The Ron Evans AM Fellowship to progress treatments for bowel cancer.…  Read more

A discovery by Hudson Institute researchers has shed more light on the causes of testicular cancer and male infertility – and provided a potential new target for treatment.…  Read more

In a world-first discovery, Hudson Institute cancer researchers have discovered two potential genetic markers which could be used to provide more personalised cancer treatments to some patients.…  Read more

Exposure of a male fetus to abnormal levels of a growth factor present during pregnancy has now been shown to directly affect development of a male baby’s sperm cells, which could lead to infertility and testicular cancer later in life.…  Read more

Sarah Russell knew something was gravely wrong with one of her twins, five-year-old Jaxon, when he became seriously ill with vomiting, nausea and unusual bruising, while his brother, Hunter, remained well.…  Read more

Women with a rare and potentially aggressive form of ovarian cancer will benefit from a grant to continue ground-breaking research into new detection and treatment methods.…  Read more

Disruptions to male babies’ development early during pregnancy could have a profound effect on a man’s future reproductive health, according to new research.…  Read more

Researchers have identified a protein in immune cells that may play a role in thwarting a type of stomach cancer, paving the way for possible prevention therapies.…  Read more

Researchers have developed a simple blood test that measures the body’s own immune response to improve diagnosis of ovarian cancer.…  Read more

A two-day workshop is being held to promote collaborative research opportunities between cancer and inflammation researchers at Hudson Institute and the Department of Immunology at the University of Toronto.…  Read more

Congratulations to Dr Mohamed Saad, who has been awarded a Cancer Council Victoria (CCV) Postdoctoral Cancer Research Fellowship to inform the design of better treatment approaches in lung cancer.…  Read more

Five Hudson Institute researchers have been awarded one-year Medicine/Science grants totalling nearly $300,000 by The CASS Foundation, to advance their research projects into mitochondrially-driven cancers, ovarian cancer, Parkinson’s disease, primary aldosteronism and endometriosis in 2020.…  Read more

Congratulations to Dr Daniel Gough for receiving a Mid-Career Research Fellowship from the Victorian Cancer Agency (VCA) for his research in developing new therapies for small cell lung cancer (SCLC).…  Read more

We are pleased to announce that the inaugural recipient of the Daniel Wilson Memorial PhD Scholarship is Alice West—who, thanks to tremendous fundraising efforts, will have her research costs fully covered over the entirety of her 3–4-year study in stomach cancer.…  Read more

Hudson Institute researchers discover why the most common form of childhood brain cancer is seen in boys more than girls, and identify a potential biomarker for less aggressive treatment.…  Read more

Hudson Institute researchers have identified a target for controlling the development of colon cancer that could lead to novel treatment strategies.…  Read more

Improved treatments for a range of cancers could be possible following a discovery that stomach cancer is mainly driven by a different process than previously believed.…  Read more

For the month of ‘frocktober’ ovarian cancer researchers, Dr Maree Bilandzic and Dr Amy Wilson swapped their white lab coats for colourful frocks as part of the Frocktober campaign to raise funds and awareness for ovarian cancer research.…  Read more

Highly mobile, invasive ovarian cancer cells called ‘leader cells’ have been discovered as the cells that lead the attack on healthy tissue.…  Read more

A group of 26 students from Ivanhoe Girls’ Grammar School have fundraised to create the school’s inaugural Early Career Ovarian Cancer Research Travel Award, which has been awarded to Hudson Institute’s own Dr Amy Wilson.…  Read more

Reproductive health research leader Professor Jock Findlay AO has been elected a Fellow of the Australian Academy of Health and Medical Sciences (AAHMS), acknowledging his significant achievements in reproductive health research.…  Read more

Our genetic material can predispose us to a number of diseases and conditions. Technologies to edit or change our genes are still in their infancy, so scientists are instead looking for ways to use treatments to stop genes that cause health conditions from being turned on.…  Read more

Hudson Institute is delighted to announce the success of our researchers in the new NHMRC Investigator Grant round.…  Read more

Dr Bilandzic, an ovarian cancer researcher, has been awarded $700,000 for research into deadly ovarian cancer cells called ‘leader cells’, which can survive and even thrive in response to cancer treatment. …  Read more

Two Hudson Institute researchers, Dr Jun Yang and Dr Maree Bilandzic have been successful in the 2019 IMPACT Philanthropy program, from Perpetual, which are awarded to organisations based on their strategy, outcomes, capability and leaderships.…  Read more

Professor Brendan Jenkins took part in two Metafit (high intensity interval training) sessions last weekend, including one organised in Fairfield for coaches.

These sessions were held in memory of the late fitness trainer, Daniel Wilson to raise funds for a new scholarship at Hudson Institute.…  Read more

A leading Australian fitness coach, Daniel Wilson, died in May 2019 two months after being diagnosed with stomach cancer aged just 37. Daniel was well known for introducing Metafit, a HIIT (High Intensity Interval Training) program, to Australia.

Now, those who loved Daniel are commemorating his life by raising funds for medical research that will help find earlier diagnoses and treatments for others with stomach cancer.…  Read more

The development of a drug to treat the most common type of lung cancer is a step closer …  Read more

Ovarian cancer is responsible for more deaths than any other gynaecological disease, yet it’s known as the ‘silent killer’, due to an absence of symptoms and a devastatingly low survival rate of less than 50 per cent. Our leading ovarian cancer researchers are progressing solutions to help these women – thanks to support from the…  Read more

A double-barrelled, non-surgical method to treat a rare type of ovarian cancer may provide hope for many patients.…  Read more

More than 150 leading clinicians and scientists heard from national and international experts in childhood cancer at Hudson Institute of Medical Research on Wednesday, 13 February at a highly anticipated international symposium. The symposium was made possible through the generous support of our premium partner, the Children’s Cancer Foundation, along with the Isabella and Marcus…  Read more

The discovery of how some cancer drugs can deliver a ‘double-hit’ when targeting tumour cells could lead to further advancements in treatment. A new study has challenged the long-held belief that a type of induced cell death, which is regulated by the BCL-2 family of proteins, attacks cells in only one way. The findings published…  Read more

A gene that impacts cancer cells may be vital to fertility and eye health in both men and women, according to new research by scientists at Hudson Institute of Medical Research. …  Read more

Hudson Institute researchers have identified new genetic factors that could help to uncover the causes of the rare overgrowth disorder, Beckwith-Wiedemann syndrome.…  Read more

Ovarian cancer research leaders from across Australia met at Hudson Institute of Medical Research on Thursday, 15 November, for a new research symposium focused on progressing solutions to the disease.…  Read more

Hudson Institute’s Cancer Genetics and Functional Genomics Postdoctoral Scientist, Dr Marius Dannappel, has been awarded a highly sought after Research Fellowship from the DFG (German Research Foundation) that will progress his research aimed at developing treatments for colorectal cancer. The two year early career fellowship will enable Dr Dannappel to continue his research into the…  Read more

Could the environment we live in, our diet, the chemicals we use or the medications we take affect the health and development of future generations?…  Read more

Pioneering Australian clinicians, Barry Marshall and Robin Warren first reported in 1982 that the stomach bacterium, Helicobacter pylori (H.plylori) causes gastritis and is a major risk factor in peptic ulcer disease and stomach cancer. Marshall and Warren were awarded the Nobel Prize in Physiology or Medicine in 2005 for their discovery, which has resulted in…  Read more

A collection of data extracted from more than 1000 paediatric brain tumour samples will improve Hudson Institute scientists’ ability to tackle childhood brain cancer through targeted therapies. The new Paediatric Brain Tumour Atlas (PBTA), launched by the US-based Children’s Brain Tumour Tissue Consortium (CBTTC) on Monday, includes data collected from 30 unique childhood brain tumour…  Read more

A new study has identified a genetic mutation that could be linked to an aggressive type of ovarian cancer driven by hormones. A team of scientists at Hudson Institute of Medical Research, with collaborators at the Peter MacCallum Cancer Centre and the University of Western Australia, used large-scale genome sequencing to map the tumour genome…  Read more

Hudson Institute has had outstanding success in the recent National Health and Medical Research Council (NHMRC) Fellowship and Development Grant announcements.…  Read more

Scientists have uncovered a protein that could be responsible for endometrial cancer cells detaching from the womb and implanting elsewhere in the body – but a drug that is in development could help. Endometrial cancer is the most commonly diagnosed gynaecological cancer in Australian women, yet there is no early diagnostic test and limited treatment…  Read more

A clinical trial of a screening test developed by Hudson Institute scientist, Dr Andrew Stephens to detect ovarian cancer in its early stages is about to start in a large group of Victorian and South Australian women, thanks to funding from the Ovarian Cancer Research Foundation (OCRF). About 300 women will be recruited to the…  Read more

A naturally occurring hormone could help make chemotherapy much more effective for many Australians with lung cancer, according to new findings from Sydney and Melbourne researchers. And the hormone – known as follistatin – also appears to prevent kidney damage, a serious side effect of chemotherapy. The promising new ‘two birds, one stone’ treatment approach, which was…  Read more

‘Clusters’ of immune cells are associated with advanced stomach cancers, but they provide few clinical or prognostic clues for these tumours, a new Hudson Institute study has found. Professor Brendan Jenkins, the study’s co-author, says that in some other cancers, the presence of these clusters, called immune cell aggregates, indicates improved patient survival – but…  Read more

The Active Ratio Test represents an exciting step forward in innovative ovarian cancer research. Should it be successful, a test as simple as taking a swab or blood sample will result in the early detection of ovarian cancer in women who otherwise exhibit no symptoms. Vague and misleading symptoms, combined with the need for invasive…  Read more

A new PhD scholars program in paediatric cancer precision medicine has been established at Hudson Institute of Medical Research with co-funding from the Children’s Cancer Foundation. The program will train the next generation of scientists in advanced functional and structural genomics, development of patient-centric preclinical models, bioinformatics analytics and translational research with the aim of…  Read more

‘Off-the-shelf’ immunotherapies to fight aggressive forms of cancer, including relapsed ovarian and gastric cancers, are being developed in Clayton, Melbourne, thanks to almost $3 million in Federal Government funding awarded to lead participant Cartherics Pty Ltd. Hudson Institute of Medical Research and Monash University researchers are partnering with industry leaders in cell therapies to develop…  Read more

Congratulations to the 2018 recipients of The Harold Mitchell Foundation Travel Fellowships. These fellowships are equipping our young scientists with the experience, cutting-edge knowledge and professional links that will let them make a major difference to medical science both in Australia and throughout the world. The Harold Mitchell Foundation Fellowships enable a promising young Hudson…  Read more

A world-leading Melbourne innovation is rapidly changing the way cell therapies are manufactured to treat diseases including stroke and cerebral palsy, taking these treatments out of the lab and into hospitals. The new cell-processing technology, ROTEA, developed by Melbourne start-up, Scinogy in conjunction with Hudson Institute of Medical Research, is significantly reducing the costs and…  Read more

New research from Hudson Institute of Medical Research is showing how a pro-inflammatory protein could offer new hope for stomach cancer treatment. A study, led by Dr Virginie Deswaerte and Professor Brendan Jenkins, found that modifying key components of the inflammatory response in the body could help to prevent tumour growth. The findings have been…  Read more

Precision medicine is providing new hope for patients with ovarian cancer, the most common cause of death from gynaecological cancers. Only 3 out of every 10 women diagnosed with advanced stage ovarian cancer will survive after five years. These statistics haven’t improved in 30 years, but precision medicine approaches are opening up new possibilities. While…  Read more

Hudson Institute has entered into a Research and Development Alliance Agreement with RMW Cho Group Limited to provide key scientific assessment of the cancer treatment technology, Photosoft. The collaboration will initially focus on the treatment of ovarian cancer, with a view to expanding research and development projects into other forms of cancer. Hudson Institute will…  Read more

The inaugural Dr Sue Fowler Scholarship in Ovarian Cancer has been awarded to PhD student, Mrs Nazanin Karimnia to support her research into new ovarian cancer therapies. The scholarship was established in honour of the late Dr Sue Fowler, to support a Hudson Institute PhD student undertaking research into ovarian cancer. There is an urgent…  Read more

Scientists at Hudson Institute of Medical Research have identified a family of genes that could more accurately detect stomach cancer in its early stages to help improve survival rates. Stomach or gastric cancer is the third leading cause of cancer death worldwide. It is caused by the abnormal growth of cells in the lining, or…  Read more

The Hudson Monash Precision Medicine Program hopes to significantly improve treatment for childhood cancer patients with the greatest unmet clinical need – those diagnosed with brain cancers and solid tumours. Launched today (February 7) ahead of International Childhood Cancer Day on February 15, the two year program is being established with a $1.3 million investment…  Read more

Dr Jason Cain has been awarded a Victorian Cancer Agency (VCA) Mid-Career Fellowship for his research to help tackle a rare and aggressive form of childhood cancer. Dr Cain was one of 14 successful VCA funding recipients announced by Acting Minister for Health, Martin Foley as part of a $7 million investment by the Victorian…  Read more

Hudson Institute scientists will share expertise with leading international research institutions to progress research and improve treatments for children and adolescents with brain cancer. Hudson Institute has been announced as the first Australian member of the US-based Children’s Brain Tumor Tissue Consortium (CBTTC) and joins a collaborative, multi-institutional research program dedicated to the study and…  Read more

Hudson Institute has had outstanding success in the recent NHMRC Project Grant round. In addition, our researchers have been awarded an NHMRC Partnership Grant, an NHMRC Development Grant, an ARC Discovery Grant and three NMHRC Fellowships.…  Read more

Why does a common bug, Helicobacter pylori, which is present in the stomachs of around half the world’s population, drive stomach cancer in some people? Associate Professor Richard Ferrero will establish how this seemingly innocuous bacterium drives growth of a specific type of stomach tumour, thanks to generous funding from the US Department of Defense.…  Read more

For more than 50 years, the idea that cancer is caused by abnormal genes has been driving cancer research and treatment. Now, discovery research into epigenetics (how genes are switched on and off), inflammation and tissue organisation (the interaction between cells and organs) is leading scientists to acknowledge that just like the human body, cancer…  Read more

Hudson Institute’s brightest scientific minds and most promising discoveries will be progressed, thanks to support from a leading philanthropist, Mr Peter Fielding and the Fielding Foundation. The 2018 Fielding Innovation Award has been awarded to Dr Maree Bilandzic to develop more effective treatments for women with ovarian cancer. The 2018 Fielding Foundation Fellowship has been…  Read more

The gut microbiome, the vast ecosystem of bacteria that live within our digestive system, is becoming increasingly recognised for its essential role in supporting our physical and mental health.…  Read more

Investigating the role of the immune system in the fight against pancreatic cancer is the focus of innovative research at Hudson Institute, thanks to new funding announced on World Pancreatic Cancer Day.…  Read more

New research from Hudson Institute of Medical Research is paving the way for a world-first early detection test for endometrial cancer that could reduce mortality and potentially spare women from an invasive hysterectomy.…  Read more

Scientists at Hudson Institute are closer to developing an early detection test for ovarian cancer and better therapies to treat the disease, thanks to new research funding. The Ovarian Cancer Research Foundation (OCRF) has generously announced $1.4 million in grants, including funding for research projects at Hudson Institute and a grant to maintain a vital…  Read more

A team of scientists and clinicians in Clayton, Melbourne, has optimised a non-invasive technique to screen pancreatic cancer patients for responsiveness to specific drugs, and has commenced a trial with a drug currently used to treat colon cancer in the hope it may be effective in treating up to 10 per cent of pancreatic cancer patients.…  Read more

The Director Emeritus of Hudson Institute of Medical Research, Professor Evan Simpson has been acknowledged with the Honour for significant service to medical science, particularly in the field of breast cancer, as an academic and researcher.…  Read more

Hudson Institute researchers have been awarded more than $10 million in funding by the National Health and Medical Research Council (NHMRC).…  Read more

Lung cancer is the leading cause of cancer death worldwide, and is frequently associated with cachexia. Cachexia is a devastating syndrome of weight and muscle wasting, affecting as many as 80 per cent of advanced cancer patients.…  Read more

Hudson Institute of Medical Research is pleased to welcome Dr Joseph (Sefi) Rosenbluh as Director of the new Centre of Functional Genomics within the Centre for Cancer Research.…  Read more

Researchers at Hudson Institute of Medical Research are working to establish and pilot an Australian-first service for analysing the most common type of paediatric solid brain cancer tumour, medulloblastoma, to enable more effective treatment for these paediatric brain cancer patients.…  Read more

Hudson Institute has entered into an international collaborative research agreement with Ariel University (Israel) and ASCI Pharma Pty Ltd on a cancer biology project designed to translate its discoveries into patient treatments.…  Read more

Researchers at Hudson Institute of Medical Research have discovered a crucial genetic marker that heralds better treatment and outcomes for patients with advanced bladder cancer.…  Read more

A new study by Hudson Institute of Medical Research and Fiona Elsey Cancer Research Institute scientists has uncovered important differences between pre- and post- chemotherapy ovarian cancer tumours that may be used to better tackle chemotherapy resistance.…  Read more

Scientists from across the world discussing immunology research…  Read more

Lung cancer and emphysema could be diagnosed earlier and targeted with an existing drug, vastly improving patient outcomes, researchers at Hudson Institute of Medical Research have discovered…  Read more

Hudson Institute researchers Dr Simon Chu and Dr Andrew Stephens have been awarded grants totalling more than $700,000 over three years by the Ovarian Cancer Research Foundation (OCRF),  to support ongoing work to improve early-stage tumour detection and to develop better therapies for women with ovarian cancer.…  Read more

Hudson Institute Director and distinguished cancer researcher Professor Bryan Williams has been invited to speak at a Hope Funds for Cancer Research meeting in New York.…  Read more

Targeted genetic treatment for cancer is a step closer, with a world-first clinical trial set to test the effectiveness of a new class of drugs called BET inhibitors in treating prostate and colorectal cancer. A team of clinicians and researchers at Hudson Institute of Medical Research and Monash University has been awarded a $2 million…  Read more

A researcher from Hudson Institute of Medical Research in Melbourne has discovered a class of biomarkers which may be used to predict which cancer patients will respond to a new class of cancer drugs.…  Read more

Four Hudson researchers have been awarded grants totalling more than $160,000 by the CASS Foundation to further their research projects into pancreatic cancer, muscle wasting diseases and developing female contraceptives. CASS Foundation is a private philanthropic organization that supports Victorian medicine and science research projects that have the potential to lead to improved treatment and practice. Professor Brendan Jenkins, from Hudson’s Centre for Innate Immunity and Infectious…  Read more

researcher in the current climate, but to also be a recipient of an inaugural veski inspiring women fellowship, is an outstanding achievement for Hudson Institute of Medical Research’s Dr Maria Kaparakis-Liaskos. Dr Liaskos, who works within the Institute’s Centre for Innate Immunity and Infectious Diseases, submitted her grant application shortly before commencing maternity leave.…  Read more

Associate Professor Ron Firestein talks about why he moved from the US (where he worked for biotech company Genentech in San Francisco) to take up an appointment at the Hudson Institute as Director of the Centre for Cancer Research…  Read more

Hudson Institute has welcomed its newest head of the Centre for Cancer Research, Associate Professor Ron Firestein, who has relocated from San Francisco with his young family to take up the role.…  Read more

Hudson Institute’s Professor Peter Fuller has been appointed chair of the Victorian Cancer Agency Consultative Council.…  Read more

The Isabella and Marcus Paediatric Brainstem Tumour Fund have provided a grant of $84,000 to the Hudson Institute to support the work of Dr Jason Cain.…  Read more

Congratulations to Richa Kohli, the first Robert Connor Dawes PhD scholarship recipient, awarded by the Robert Connor Dawes Foundation.…  Read more

Early to mid-career researchers are set to get a boost thanks to the announcement of the $1 million Fielding Fellowship Program and Award for Innovation by Melbourne Businessman and Fielding Foundation Executive Chair, Mr Peter Fielding.…  Read more

MIMR-PHI cancer researchers, Drs George Grigoriadis and Daniel Gough were among 25 scientists recently awarded VCA funding.…  Read more